On Feb. 14, the ACC joined colleagues in medicine and patient advocacy on a comment letter to the Center for Medicare and Medicaid Services (CMS) detailing ways to improve Medicare beneficiary access to home infusion therapy.

The letter outlined that this could be done while also reducing costs, and thanked the agency for recent efforts to optimize site of care, moving patients from costly settings to the home through efforts such as the Advancing American Kidney Health initiative.

The letter encourages CMS to "1) ensure that reimbursement reflects not only services provided by a nurse in the patient's home, but also the extensive pharmacy services which are provided remotely; 2) provide reimbursement every day the drug is infused, regardless of whether a nurse is present; 3) promote timely access to new, innovative therapies; and 4) ensure patients and their providers have active discussions about their site-of-care options."

Read the full comment letter.

Keywords: ACC Advocacy, Centers for Medicare and Medicaid Services, U.S., Medicare, Home Infusion Therapy, Medicaid, Patient Advocacy, Costs and Cost Analysis

< Back to Listings